With over 800 attendees, the Redefining Early Stage Investments (RESI) Conference is an ongoing conference series providing an international platform for early stage life science companies across biotech, medtech, diagnostics and healthcare IT. RESI hosts investors from around the globe, helps create relationships, and eventually, secure funding.

The RESI NYC agenda 2 parallel tracks (biotech investor panels and device, diagnostic, and HCIT investor panels) and an all-day partnering forum